AMUNIX PHARMACEUTICALS INC has a total of 29 patent applications. It increased the IP activity by 500.0%. Its first patent ever was published in 2010. It filed its patents most often in Australia, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ATARGA LLC, TRUBION PHARMACEUTICALS and TRUBION PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | United States | 6 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Israel | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | China | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | Singapore | 1 | |
#12 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Fermentation | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Schellenberger Volker | 24 |
#2 | Wang Chia-Wei | 12 |
#3 | Thayer Desiree | 11 |
#4 | Spink Benjamin | 11 |
#5 | Yang Fan | 11 |
#6 | Silverman Joshua | 11 |
#7 | Sim Bee-Cheng | 10 |
#8 | Geething Nathan | 10 |
#9 | Podust Vladimir | 9 |
#10 | Beaber John | 9 |
Publication | Filing date | Title |
---|---|---|
US2021054077A1 | Cd3 antigen binding fragments and compositions comprising same | |
WO2020264208A1 | Egfr antigen binding fragments and compositions comprising same | |
KR20200111176A | Glass segment and bonding composition comprising the same | |
AU2015218510A1 | Extended recombinant polypeptides and compositions comprising same | |
AU2014206217A1 | Extended recombinant polypeptides and compositions comprising same |